Transfusion-Related Acute Lung Injured (TRALI): Current Concepts

Open Respiratory Medicine Journal

Volumn 9, Issue , 2015, Pages 92-96

  Alvarez P ^a,b   Carrasco, R ^c   Romero Dapueto, C ^d   Castillo, R L ^c  

^a Hospital Clínico Metropolitano Dra Eloísa Díaz Insunza   (Chile)

^b UNIVERSIDAD FINIS TERRAE   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d UNIVERSIDAD DEL DESARROLLO   (Chile)

Author keywords

Respiratory failure; Transfusion related acute lung injury

Indexed keywords

ALLOANTIBODY; CD45 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOAGGLUTININ; LEUKOCYTE ANTIBODY; PROTEINASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD TRANSFUSION; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; CELL ADHESION; CYANOSIS; DYSPNEA; EDEMA; ENDOTRACHEAL INTUBATION; EXPERIMENTAL MODEL; FEVER; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTENSION; IMMUNE MEDIATED INJURY; IMMUNE RESPONSE; LEUKOCYTE ACTIVATION; LUNG FUNCTION; LUNG VENTILATION; NEUTROPHIL; OXYGEN THERAPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TACHYCARDIA; TACHYPNEA; TRANSFUSION RELATED ACUTE LUNG INJURY; TREATMENT DURATION;

EID: 84937808377     PISSN: None     EISSN: 18743064     Source Type: Journal    
DOI: 10.2174/1874306401509010092     Document Type: Article

References (29)

1. [1] Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44: 1774-89.
2. [2] Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: Definition and review. Crit Care Med 2005; 33: 721-6.
3. [3] Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25: 573-7.
4. [4] Vlaar AP, Schultz MJ, Juffermans NP. Transfusion-related acute lung injury: A change of perspective. Neth J Med 2009; 67: 320-6.
5. [5] Kleinman S. A perspective on transfusion-related acute lung injury two years after the Canadian Consensus Conference. Transfusion 2006; 46: 1465-8.
6. [6] Añón JM, García de Lorenzo A, Quintana M, et al. Transfusionrelated acute lung injury. Med Intensiva 2010; 34: 139-49.
7. [7] Marik PE, Corwin HL. Acute lung injury following to transfusion: expanding the definition. Crit Care Med 2008; 36: 3080-4.
8. [8] Swanson K, Dwyre DM, Krochmal J, Raife TJ. Transfusion-related acute lung injury (TRALI): current clinical and pathophysiologic considerations. Lung 2006; 184: 177-85.
9. [9] Müller MC, Juffermans NP. Transfusion-related acute lung injury: A preventable syndrome? Expert Rev Hematol 2012; 5: 97-106.
10. [10] Bierling P, Bux J, Curtis B, et al. Recommendations of the ISBT working party on granulocyte immunobiology for leucocyte antibody screening in the investigation and prevention of antibodymediated transfusion-related acute lung injury. Vox Sang 2009; 96: 266-9.
11. [11] Bux J. Transfusion-related acute lung injury (TRALI): A serious adverse event of blood transfusion. Vox Sang 2005; 89: 1-10.
12. [12] Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005; 105: 2266-73.
13. [13] Jaworski K, Maślanka K, Kosior DA. Transfusion-related acute lung injury: A dangerous and under diagnosed noncardiogenic pulmonary edema. Cardiol J 2013; 20: 337-44.
14. [14] Shaz BH. Giving TRALI the one-two punch. Blood 2012; 119: 1620-1.
15. [15] Bux J, Sachs U. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007; 136: 788-99.
16. [16] Seeger W, Schneider U, Kreusler B, et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 1990; 76: 1438-44.
17. [17] Sachs UJ, Hattar K, Weissmann N, et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat model. Blood 2006; 107: 1217-19.
18. [18] Silliman CC, Bjornsen AJ, Wyman TH, et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003; 43: 633-40.
19. [19] Lögdberg LE, Vikulina T, Zimring JC, Hillyer CD. Animal models of transfusion-related acute lung injury. Transfus Med Rev 2009; 23: 13-24.
20. Bux J, Becker F, Seeger W, et al: Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1- specific antibodies in donor blood. Br J Haematol 1996; 93: 707- 13.
21. [21] Vlaar AP, Zweers MM, Schultz MJ, et al. Developing specific therapeutic strategies for transfusion-related acute lung injury: An overview of potentially useful animal models. Cardiovasc Hematol Agents Med Chem 2007; 5: 319-26.
22. [22] Woźniak MJ, Bowring C, Lucas G, Ridgwell K. Detection of HNA-3a and -3b antibodies using transfected cell lines and recombinant proteins. Transfusion 2012; 52: 1458-67.
23. [23] Ritter C, da Cunha AA, Echer IC, et al. Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide induced acute lung injury in the rat. Crit Care Med 2006; 34: 471-7.
24. [24] Aravinthan A, Sen S, Marcus N. Transfusion-related acute lung injury: A rare and life-threatening complication of a common procedure. Clin Med 2009; 9: 87-9.
25. [25] Triulzi DJ. Transfusion-related acute lung injury: an update. Hematol Am Soc Hematol Educ Program 2006: 497-501.
26. [26] Fadeyi EA, De Los Angeles MM, Wayen AS, et al. The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion 2007; 47: 545-50.
27. [27] Gordo Vidal F, Delgado Arnaiz C, CalvoHerranz E. Mechanical ventilation induced lung injury. Med Intensiva 2007; 31: 18-26.
28. [28] Vlaar AP, Juffermans NP. Transfusion-related acute lung injury: A clinical review. Lancet 2013; 382: 984-94.
29. [29] Moore SB. Transfusion-related acute lung injury (TRALI): Clinical presentation, treatment, and prognosis. Crit Care Med 2006; 34:S114-7.